Literature DB >> 2420767

Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen.

F Triebel, S de Roquefeuil, C Blanc, D J Charron, P Debre.   

Abstract

The expression of interleukin 2 (IL2) receptor and HLA-DR, DQ, and DP antigens on the surface of four diphtheria toxoïd (DT)-specific T lymphocyte clones (TLC) and two TLC specific for an allogeneic EBV-transformed cell line was investigated with the use of monoclonal antibodies (MoAbs) that recognize defined molecules or epitopes. Incubation of a resting TLC with IL2 resulted in a 10- to 30-fold increase in the level of DR, DQ, and Tac antigen expression. On the other hand, incubation of an activated TLC with IL2 decreased for 1 to 6 hr the level of expression of these three antigens. Anti-FA MoAbs did not react with any of the TLC tested suggesting that the expression of DR, DQ, and DP antigens is dissociated on activated TLC. Surface-marker analysis with anti-DR MoAbs indicated that DR epitopes were differently expressed at some activation stages of the TLC. Functional studies showed that activated TLC can stimulate in MLR, AMLR, and PLT. These proliferative responses were inhibited by preincubating the TLC with anti-DR MoAbs suggesting that the stimulatory determinants were predominantly DR molecules. In addition, some TLC can act as antigen presenting cells in DT-specific proliferative responses. These results indicate that MHC class II molecules on activated T lymphocytes may be relevant for the control of specific immunologic responses in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420767     DOI: 10.1016/0198-8859(86)90005-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells.

Authors:  N Chirmule; V S Kalyanaraman; H Slade; N Oyaizu; S Pahwa
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

2.  HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.

Authors:  B Gansbacher; K S Zier
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

Review 3.  Current concepts in DRA gene regulation.

Authors:  J P Ting
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  Increased HLA-DR and decreased CD3 on human intestinal intraepithelial lymphocytes: evidence of activation?

Authors:  M Abuzakouk; D Kelleher; C Feighery; C O'Farrelly
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

5.  Class-II and IL2 receptor positive cells in the pancreas of NOD mice.

Authors:  A Signore; A Cooke; P Pozzilli; G Butcher; E Simpson; P C Beverley
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

6.  The control of class II expression on T cells is independent of the regulation of Tac and the induction of proliferation.

Authors:  S Salvadori; A Pizzimenti; S Cohen; K S Zier
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 7.  T cells as vehicles for cancer vaccination.

Authors:  Adham S Bear; Conrad R Cruz; Aaron E Foster
Journal:  J Biomed Biotechnol       Date:  2011-10-27

8.  Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells.

Authors:  S Sidhu; S Deacock; V Bal; J R Batchelor; G Lombardi; R I Lechler
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.